(RTTNews) - Thursday, Gogo, Inc. (GOGO), a telecom service provider, signed a communications lease worth more than $15 million to provide GEO satellite connectivity to a government customer.
(RTTNews) - Cullinan Therapeutics (CGEM) announced Thursday that the first patient has been dosed in its pivotal Phase 2 study of CLN-049 in patients with relapsed or refractory acute myeloid leukemia (AML).
The S&P 500 Index ($SPX ) (SPY ) closed down by -0.22% on Wednesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down by -0.66%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.21%. December E-mini S&P futures (ESZ26 ) fell -0.27%, and December E-mini...
(RTTNews) - SOPHiA GENETICS (SOPH) and Myriad Genetics, Inc. (MYGN) announced Thursday a collaboration to advance new prostate cancer-specific genomic instability score (PrGIS) technology to support precision oncology approaches with AstraZeneca (AZN).
The S&P 500 Index ($SPX ) (SPY ) closed down by -0.22% on Wednesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down by -0.66%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.21%. December E-mini S&P futures (ESZ26 ) fell -0.27%, and December E-mini...
Fintel reports that on October 8, 2026, Stifel initiated coverage of Entegris (NASDAQGS:ENTG) (BMV:ENTG) with a Buy recommendation. This initiation of coverage represents the primary action on this date for the company.Entegris, Inc. is a United States-based global corporation sp
(RTTNews) - Byrna Technologies Inc. (BYRN), a personal defense solutions provider, on Thursday posted a net loss for the third quarter of fiscal 2026, hurt by increased expenses and decreased revenue.
Redwire (NYSE: RDW) is becoming a much larger defense business as Edge Autonomy reshapes its revenue mix, backlog, and growth opportunity. Strong bookings and repeat programs point to potential upside, but the real test is whether that scale can produce better margins and stronge
(RTTNews) - After ending the previous session modestly lower but well off their worst levels, stocks are likely to see further downside in early trading on Thursday. The major index futures are currently pointing to initial weakness on Wall Street, with the S&P 500 futures down b
(RTTNews) - Bay Street looks headed for a weak start on Thursday amid rising concerns about an escalation in Middle East tensions, and the resultant sharp surge in oil prices.
(RTTNews) - Editas Medicine, Inc. (EDIT) has received regulatory and ethics approval in Australia to begin the first-in-human Phase 1/2 clinical trial of EDIT-401, an experimental gene editing therapy designed to treat hyperlipidemia, or high levels of LDL cholesterol.